cepharanthine has been researched along with Acute Lung Injury in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Hu, G; Huang, H; Qian, A; Wang, C; Xu, H | 1 |
| Chou, WC; Huang, CJ; Kao, MC; Sheu, JR; Yang, CH | 1 |
2 other study(ies) available for cepharanthine and Acute Lung Injury
| Article | Year |
|---|---|
Cepharanthine, an alkaloid from Stephania cepharantha Hayata, inhibits the inflammatory response in the RAW264.7 cell and mouse models.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzylisoquinolines; Bronchoalveolar Lavage Fluid; Cell Line; Cell Survival; Dexamethasone; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; I-kappa B Proteins; Inflammation; Interleukin-1beta; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred BALB C; NF-KappaB Inhibitor alpha; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Plant Preparations; Stephania; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2014 |
Cepharanthine mitigates lung injury in lower limb ischemia-reperfusion.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzylisoquinolines; Blood Gas Analysis; Bronchoalveolar Lavage Fluid; Cyclooxygenase 2; Drug Evaluation, Preclinical; Heme Oxygenase-1; I-kappa B Proteins; Lung; Male; Malondialdehyde; Nitric Oxide; Phytotherapy; Plant Extracts; Random Allocation; Rats, Sprague-Dawley; Reperfusion Injury; Stephania | 2015 |